Stocktoria
Damora Therapeutics, Inc. DMRA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-10-29
Damora Therapeutics, Inc. statistics & valuation
Market cap$1.6B
P / B6.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -80.5% | -125.1% | -100.3% | -84.2% | -42.3% |
| Return on equity | -87.3% | -135.4% | -118.6% | -99.8% | -44.1% |
| Current ratio | 12.98 | 14.07 | 6.31 | 5.75 | 24.23 |
Source: SEC EDGAR filings · CIK 0001800315 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.